Healthcare Dive reports that US regulators have finalised a cut to Medicare payments for doctors in 2027, along with other policy changes aimed at reducing duplicative reimbursement. Providers criticised the move, arguing it could further destabilise the sector.
This decision matters for senior executives in healthcare and pharma, as changes to provider reimbursement can affect network stability and patient access. Leaders should monitor how these adjustments may influence contract negotiations and care delivery models.
